Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of LRMR will decline by -10.60% over the next 2 Weeks and hit $3.71 by Wednesday, May 20, 2026. In that time frame, LRMR's share price is expected to range between $3.50 and $3.91.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 20, 2026 | 3.50 | 3.71 | 3.91 |
| May 19, 2026 | 3.51 | 3.71 | 3.90 |
| May 18, 2026 | 3.58 | 3.77 | 3.96 |
| May 15, 2026 | 3.68 | 3.87 | 4.07 |
| May 14, 2026 | 3.70 | 3.89 | 4.07 |
| May 13, 2026 | 3.71 | 3.90 | 4.10 |
| May 12, 2026 | 3.70 | 3.89 | 4.08 |
| May 11, 2026 | 3.76 | 3.95 | 4.14 |
| May 8, 2026 | 3.87 | 4.06 | 4.25 |
| May 7, 2026 | 3.89 | 4.08 | 4.27 |
LRMR shares rose +3.49% in Wednesday, May 6, 2026's trading session, rising from a previous close of $4.01 to move at $4.15. The stock demonstrated notable intraday movement (see LRMR's key stats for a full breakdown), fluctuating between $4.00 and $4.28, a +7.00% trading range. While recent weeks have seen some volatility, LRMR has managed to secure a -9.19% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 2.41M shares changing hands, 469.85K more than the previous session. This amounted to $10.02M in total market activity.
Will LRMR Continue Its Downward Trend?
According to analyst ratings and projections for LRMR, Larimar Therapeutics, Inc. shares are anticipated to decrease by -6.06%, potentially reaching $3.91 per share by May 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for LRMR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the LRMR stock forecast, now is not the best time to buy LRMR stock because its current trading price is +11.86% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on LRMR covering social and institutional perspectives.
LRMR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into LRMR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.62% to 44.04%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.24%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.16%, maintains a neutral outlook for the long term. Insights into LRMR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Larimar Therapeutics Short-Term Forecasts
LRMR Forecast For Next 5 Days
Our algorithm anticipates Larimar Therapeutics (LRMR) stock could hit $3.44 by May 13, 2026. This represents a -17.11% fall from today's price, following a -1.54% change over the past five days.
LRMR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Larimar Therapeutics, Inc. (LRMR) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.77, which would mean a -9.16% decrease from the current price of $4.15. Projections for this period range from a high of $5.44 to a low of $2.46.
LRMR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Larimar Therapeutics's price over the next three months point to a rise. LRMR stock is expected to peak at $16.50 on Aug 03, 2026 after potentially dipping to $8.28 on May 18, 2026. On average, LRMR is likely to trade around $12.52 in the coming 90 days.
Larimar Therapeutics Stock Forecast 2025
Based on our predictive models, Larimar Therapeutics (LRMR) is expected to trade between $8.28 and $20.16 throughout 2026. This would result in an average price of $13.64, potentially offering investors a +228.67% return from current levels.
Larimar Therapeutics, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, Larimar Therapeutics, Inc. (LRMR) is positioned to show a strong performance in May 2026. The price is predicted to move between $8.28 and $10.51, settling at an average of $9.29. This could translate to a +123.86% gain.
June 2026
Based on current market signals, Larimar Therapeutics, Inc. is projected to trend june 2026. We forecast a trading range from $10.71 to $14.28, with a likely average price of $13.15. Investors could expect a potential return of +216.87%.
July 2026
Our predictive algorithms indicate Larimar Therapeutics, Inc. stock may see a shift in July 2026. The expected range spans $11.98–$15.83, with an average target of $13.56. This represents a positive outlook and a possible gain of +226.75%.
August 2026
Analyzing established trends, Larimar Therapeutics, Inc. looks set to move in August 2026. Projections place the stock between $13.30 and $16.50, averaging around $15.25. This suggests a +267.47% gain from current levels.
September 2026
Market indicators suggest Larimar Therapeutics, Inc. could experience notable changes during September 2026. Prices could fluctuate within $11.73 to $16.51, with a midpoint forecast of $14.75. The stock might deliver a +255.42% gain.
October 2026
Forecasting for October 2026, models estimate that Larimar Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $9.86 and $15.70, averaging $12.88. This signals a positive trajectory with potential returns around +210.36%.
November 2026
According to our latest forecast models, Larimar Therapeutics, Inc. (LRMR) is positioned to show a strong performance in November 2026. The price is predicted to move between $12.43 and $20.16, settling at an average of $16.04. This could translate to a +286.51% gain.
December 2026
Based on current market signals, Larimar Therapeutics, Inc. is projected to trend december 2026. We forecast a trading range from $8.90 to $17.78, with a likely average price of $13.44. Investors could expect a potential return of +223.86%.
January 2027
Our predictive algorithms indicate Larimar Therapeutics, Inc. stock may see a shift in January 2027. The expected range spans $7.84–$17.41, with an average target of $12.64. This represents a positive outlook and a possible gain of +204.58%.
February 2027
Analyzing established trends, Larimar Therapeutics, Inc. looks set to move in February 2027. Projections place the stock between $8.38 and $22.60, averaging around $15.22. This suggests a +266.75% gain from current levels.
March 2027
Market indicators suggest Larimar Therapeutics, Inc. could experience notable changes during March 2027. Prices could fluctuate within $8.17 to $22.06, with a midpoint forecast of $14.60. The stock might deliver a +251.81% gain.
April 2027
Forecasting for April 2027, models estimate that Larimar Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $8.92 and $25.58, averaging $16.67. This signals a positive trajectory with potential returns around +301.69%.
May 2027
According to our latest forecast models, Larimar Therapeutics, Inc. (LRMR) is positioned to show a strong performance in May 2027. The price is predicted to move between $8.07 and $22.87, settling at an average of $15.58. This could translate to a +275.42% gain.
LRMR's history of dividends and stock splits also plays a role in long-term investor confidence.